The QualityStocks Daily Thursday, July 3rd, 2025

Today's Top 3 Investment Newsletters

QualityStocks(LIXT) $2.8300 +40.10%

TechMediaWire(GBUX) $2.2470 +33.75%

StocksToBuyNow(APAAF) $0.1200 +26.32%

The QualityStocks Daily Stock List

Lixte Biotechnology (LIXT)

QualityStocks, TopPennyStockMovers, MarketClub Analysis, PennyStockScholar, StocksEarning, Premium Stock Alerts, Fierce Analyst, HotOTC, INO Market Report, Money Wealth Matters, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Buzz Stocks, PoliticsAndMyPortfolio.com, Wall Street Mover, Profitable Trader Authority, Real Pennies, Small Cap Firm, StockOnion, StockWireNews and PoliticsAndMyPortfolio reported earlier on Lixte Biotechnology (LIXT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) (FRA: 864) is a drug discovery firm that utilizes biomarker technology to identify enzyme targets associated with severe common ailments and design new compounds to attack these targets.

The firm has its headquarters in East Setauket, New York and was incorporated in 2005, on Au-gust 5th by Robert B. Royds and John S. Kovach. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United States.

The company is party to a collaboration agreement with Oncode Institute, the Netherlands Can-cer Institute, and the Spanish Sarcoma Group. It is also party to a clinical trial research agreement with the Research Institute Hospital Inc. and the Moffitt Cancer Center.

The enterprise mainly focuses on protein phosphatases inhibitors which can be used solely or in combination with immune checkpoint blockers, x-ray and/or cytotoxic agents. Its products port-folio is comprised of 2 major categories of compounds that are in different stages of clinical and pre-clinical development. The enterprise develops 2 series of pharmacologically active drugs, which include the LB-200 series for the treatment of cancer, neurodegenerative ailments and chronic hereditary illnesses like Gaucher’s disease; and the LB-100 series, which is made up of new structures that may be useful in the treatment of cancers, as well as metabolic and vascular illnesses.

Lixte Biotechnology (LIXT), closed Thursday's trading session at $2.83, up 40.099%, on 64,132,966 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.64/$4.25.

Know Labs (KNW)

QualityStocks, MarketClub Analysis, Jeff Bishop, The Stock Dork, Premium Stock Alerts and MarketBeat reported earlier on Know Labs (KNW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Know Labs Inc. (NYSE American: KNW) is a medical device firm focused on devel-oping and commercializing proprietary biosensor technologies.

The firm has its headquarters in Seattle, Washington and was incorporated in 1998, on October 8th by Ronald Peter Erickson. Prior to its name change in May 2018, the firm was known as Visualant Inc. It operates as part of the scientific and technical instru-ments industry, under the technology sector. The firm serves consumers in the United States.

The company is committed to making a difference in the lives of millions of individu-als globally by developing convenient and affordable non-invasive medical diagnos-tics solutions.

The enterprise operates through the Development of Bio-RFID and ChromaID Tech-nology, Particle, Technology, and AI Sales of NFT Products segments. Its proprietary platform technologies include ChromaID and Bio-RFID, which utilize electromagnet-ic energy along the electromagnetic spectrum to perform analytics. Bio-RFID is a non-invasive diagnostic technology platform for medical diagnostics. This platform uses electromagnetic energy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application of its technology is a glucose monitor de-vice, the UBAND. It will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and pre-diabetes to manage this medical condition.

Know Labs (KNW), closed Thursday's trading session at $2.45, up 26.943%, on 1,423,925 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.33/$20.

Windtree Therapeutics (WINT)

QualityStocks, TraderPower, Premium Stock Alerts, MarketBeat, The Stock Dork, StockMarketWatch, MarketClub Analysis, 360 Wall Street, Wall St. Warrior, The Online Investor, StreetInsider, Small Caps, Penny Stocks United, InvestorsUnderground and InvestorPlace reported earlier on Windtree Therapeutics (WINT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Windtree Therapeutics Inc. (NASDAQ: WINT) is a medical device and clinical-stage biotechnol-ogy firm that is engaged in developing therapies for treating cardiovascular and acute pulmonary ailments.

The firm has its headquarters in Warrington, Pennsylvania and was founded in 1992, on November 6th by James S. Kuo and Evan Myrianthopoulos. Prior to its name change in April 2016, the firm was known as Discovery Laboratories Inc. The firm operates in the healthcare sector, under the biotech and pharma sub-industry and serves consumers in the U.S.

The enterprise is party to a collaboration agreement with the University of Milan-Bicocca, which entails discovering and developing new SERCA2a compounds for treating acute and chronic hu-man heart failure. The enterprise is a subsidiary of Lee’s Pharmaceutical Holdings Ltd.

Windtree Therapeutics’ product pipeline is made up of a formulation developed for treating genet-ically associated hypertension which is known as Rostafuroxin and is currently undergoing phase 2 clinical trials; a lyophilized surfactant indicated for treating lung injuries caused by the coronavirus infection; an aerosolized surfactant indicated for the treatment of respiratory distress syndrome in premature infants dubbed Aerosurf, which is currently undergoing phase 2 clinical trials; and a drug formulation developed for treating early cardiogenic shock and acute decompensated heart failure dubbed Istaroxime, which is in phase 2a and 2b clinical trials.

Windtree Therapeutics (WINT), closed Thursday's trading session at $0.9292, up 20.6753%, on 81,546,279 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.36/$737.435.

Gryphon Digital Mining (GRYP)

MarketClub Analysis, StockWireNews, Fierce Analyst, QualityStocks, Premium Stock Alerts, MarketBeat, Jeff Bishop, Bull Market Briefs, Broad Street and 360 Wall Street reported earlier on Gryphon Digital Mining (GRYP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gryphon Digital Mining Inc. (NASDAQ: GRYP) is a Bitcoin mining firm engaged in the provi-sion of carbon-neutral Bitcoin mining services with zero carbon footprint.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in October 2020. It operates as part of the cryptocurrency exchanges and trading platforms industry, under the finan-cial services sector. The firm serves consumers in the United States.

The company’s mission is to power and run scalable, efficient AI computing and Bitcoin mining operations. Gryphon Digital Mining is party to a definitive agreement to acquire an asset ex-pected to deliver over 4GW of potential power capacity from Captus Energy in Southern Alber-ta, which would position it to become a leading provider of AI and high-performance computing infrastructure in North America. This facility leverages dual natural gas supplies, world-class car-bon sequestration capabilities, and industry-leading expertise to deliver reliable, cost-effective computing power at scale.

The enterprise operates a cryptocurrency mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algo-rithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards. It operates approximately 9,660 bitcoin ASIC mining computers from Bitmain Technologies Limited, that it has installed at third-party hosted mining data centers located in Pennsylvania and New York.

Gryphon Digital Mining (GRYP), closed Thursday's trading session at $1.31, up 11.9658%, on 18,197,712 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.1255/$2.93.

TMC The Metals Company (TMC)

StocksEarning, StockEarnings, Schaeffer's, QualityStocks, MarketBeat, MarketClub Analysis, TradersPro, Premium Stock Alerts, Trades Of The Day, The Street, StockReport, Investors Underground, InvestorPlace and InsiderTrades reported earlier on TMC The Metals Company (TMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TMC The Metals Company Inc. (NASDAQ: TMC) is an electric car battery metal firm that is en-gaged in the collection, processing and refining of polymetallic nodules.

The firm has its headquarters in Vancouver, Canada. Prior to its name change, the firm was known as Sustainable Opportunities Acquisition Corp. It operates as part of the metals and mining industry and serves consumers around the globe.

The company is focused on recovering metals from nodules in order to support demand from elec-tric car and battery production. Its collection of polymetallic nodules decreases the social and envi-ronmental impact of primary metal production, which it hopes could lead to a significant reduction of or total elimination of tailings.

The enterprise’s polymetallic nodules are obtained from the Clarion Clipperton Zone seafloor. This zone is found in the eastern part of the Pacific Ocean and is made up of abyssal plains and other formations. It occupies about 4500 miles and is known to not only contain a diversity and abun-dance of life but also manganese nodule resources. The enterprise holds commercial and explora-tion rights to 3 contract areas which host nodules that contain manganese, cobalt sulfate, copper and nickel sulfate. It produces these metals to power electric cars and store clean energy.

TMC The Metals Company (TMC), closed Thursday's trading session at $7.11, up 11.442%, on 19,253,357 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.721/$8.115.

Viomi Technology (VIOT)

StockEarnings, StocksEarning, QualityStocks, The Stock Dork, InvestorPlace, FreeRealTime and Daily Trade Alert reported earlier on Viomi Technology (VIOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viomi Technology Co. Ltd (NASDAQ: VIOT) is a holding firm that is engaged in the develop-ment and sale of IoT-enabled smart home products.

The firm has its headquarters in Guangzhou, the People’s Republic of China and was incorporated in May 2014 by Xiao Ping Chen. It serves consumers in China.

The company is party to a strategic partnership with Xiaomi Corporation. It sells its products di-rectly to consumers through offline experience stores, e-commerce channels like Suning, Tmall, JD.com, Youpin and its online platform Viomi Store mobile application. Its platform offers an at-tractive entry point into the consumer home, allowing consumers to interact with an extensive port-folio of IoT products that make everyday life more enjoyable, efficient and convenient.

The enterprise provides IoT enabled (Internet-of-Things) smart home products which include smart kitchen products like gas stoves, range hoods, dishwashers, oven steamers and refrigerators; smart water purification systems; and other smart products including smart TVs, smart locks, sweeper robots, smart water kettles, water heaters, washing machines and air conditioning systems, among other smart devices. In addition to this, it offers a suite of complementary small appliances and con-sumable products. These include food waste disposals, smart toilets, stainless-steel insulated water bottles, water filter pitchers, rice cookers, portable fans and blenders. The enterprise also offers value-added services.

Viomi Technology (VIOT), closed Thursday's trading session at $1.66, up 11.4094%, on 767,612 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.825/$2.38.

Tilray (TLRY)

QualityStocks, Schaeffer's, InvestorPlace, StockEarnings, StocksEarning, The Street, CannabisNewsWire, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Zacks, BUYINS.NET, Investopedia, CFN Media Group, Premium Stock Alerts, Early Bird, CNBC Breaking News, INO Market Report, The Street Report, Daily Profit, StreetAuthority Daily, FreeRealTime, Earnings360, Top Pros' Top Picks, Trading For Keeps, Trading Concepts, Prism MarketView, The Rich Investor, Tip.us, InvestmentHouse, Inside Trading, Daily Wealth, AllPennyStocks, InsiderTrades, Investment House, Eagle Financial Publications, Outsider Club, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TipRanks, TheTradingReport, The Night Owl, StrategicTechInvestor, MarketClub, Rick Saddler, Investors Alley, Money Morning, 360 Wall Street, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground, InvestorsObserver Team and Stock Up Featured reported earlier on Tilray (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tilray, Inc. (NASDAQ: TLRY) is a pharmaceutical firm that is engaged in research, growing, pro-duction and distribution of cannabinoids, recreational and medical marijuana. The firm operates through its Hemp and Cannabis Segments.

The firm’s Hemp segment sales are made up of broad spectrum hemp extract that contains CBD, hemp food and hemp seed, which are sold directly to consumers, or to wholesalers and retailers, in unlicensed operations. On the other hand, its Cannabis segment sales are made up of medical, adult-use and huge sales of marijuana under regulated licenses, which are sold directly to patients as well as to governments, pharmacies, wholesalers and retailers. The firm also provides its prod-ucts to researchers for commercial purposes, as well as for clinical research applications and com-passionate access.

Tilray was founded on January 24 in 2018 and is based in Nanaimo, Canada. The firm operates in other countries apart from Canada, including the United Kingdom, Argentina, the U.S., Australia, Switzerland, Chile, South Africa, Portugal, Croatia, New Zealand, Cyprus, Ireland, the Czech Re-public, Israel and Germany.

Tilray develops marijuana based medicines, drops, dried marijuana and marijuana extracts, as well as oil products. The firm sells these products through various brands under it, including Manitoba Harvest, Dubon and Canaca. The firm’s subsidiary - FHF Holdings Ltd, also markets, manufac-tures and distributes consumer products that are hemp-based. Apart from a partnership with AB InBev to develop marijuana-infused drinks, the company recently announced that it would be merging with Aphria Inc., another Canadian cannabis firm.

Tilray (TLRY), closed Thursday's trading session at $0.5387, up 11.0264%, on 43,044,202 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.3507/$2.15.

MicroAlgo (MLGO)

Premium Stock Alerts, QualityStocks, MarketClub Analysis, Timothy Sykes, InvestorsUnderground, Investors Underground, 360 Wall Street, Tim Bohen, INO Market Report, The Stock Dork, stockstotrade, Money Wealth Matters and Broad Street reported earlier on MicroAlgo (MLGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MicroAlgo Inc. (NASDAQ: MLGO) is an information technology firm that is focused on the development and delivery of central processing algorithm solutions to consumers in internet ad-vertisement, gaming and intelligent chip industries.

The firm has its headquarters in Shenzhen, China. Prior to its name change, the firm was a hold-ing company known as Venus Acquisition Corp. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in the People’s Republic of China.

The company operates through two segments, Central Processing Algorithm Services, and Intelli-gent Chips and Services. It provides comprehensive solutions to customers by integrating central processing algorithms with software or hardware, or both, thereby helping them to increase the number of customers, improve end-user satisfaction, achieve direct cost savings, reduce power consumption, and achieve technical goals. The company operates as a subsidiary of WiMi Holo-gram Cloud Inc.

The enterprise’s service offerings include algorithm optimization, accelerating computing power without the need for hardware upgrades, data processing, and data intelligence services. It also engages in the resale of intelligent chips and accessories; and provision of software development.

MicroAlgo (MLGO), closed Thursday's trading session at $0.682, up 10%, on 48,103,893 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.501/$185.2.

Grande Portage Resources (GPTRF)

We reported earlier on Grande Portage Resources (GPTRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Grande Portage Resources Limited (OTCQB: GPTRF) (CVE: GPG) (FRA: GPB) is an explora-tion stage firm focused on exploring for and developing natural resource properties in the United States.

Grand Portage Resources has its headquarters in Vancouver, Canada, was founded in 1973 and officially incorporated in 1984, on October 17th. It operates as part of the gold mining industry, under the basic materials sector. The firm serves consumers around the world.

The enterprise’s principal business activities focus on the exploration for gold in Alaska. It holds 100% interest in the Herbert Gold Property located roughly 25km north of Juneau, Alaska. The Herbert property, now the New Amalga gold deposit, is an exploration stage, partially drill-tested, high-grade, gold mineralized mesothermal quartz vein system in the historic Juneau Gold Belt of southeast Alaska. This system is open to length and depth and is host to at least 6 parallel vein structures exposed at surface. The project lies prominently within the 160km long Juneau Gold Belt, which has produced more than 8 million ounces of gold. The project comprises of 91 unpatented lode claims located south of Coeur Alaska's profitable Kensington gold mine.

The company, which seeks to maximize the benefit of its project development by investing in the local state economy and creating long-term job opportunities for the community of Juneau, re-mains committed to advancing the New Amalga project to become the next great gold mine in Alaska. This may encourage additional investments into the company and help bolster Grande Portage Resources’ overall growth.

Grande Portage Resources (GPTRF), closed Thursday's trading session at $0.142, up 1.4286%, on 69,400 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.101/$0.2808.

Coinbase Global Inc. (COIN)

Schaeffer's, QualityStocks, Zacks, MarketClub Analysis, InvestorPlace, CryptoCurrencyWire, The Street, BillionDollarClub, MarketBeat, StockEarnings, CurrencyNewsWire, Prfmonline, Early Bird, Greenbackers, Kiplinger Today, INO Market Report, Investopedia, SmallCapVoice, OTCPicks, The Online Investor, Ceocast News, The Wealth Report, CoolPennyStocks, HotOTC, InsiderTrades, Daily Trade Alert, FreeRealTime, TradersPro, Trades Of The Day, StockEgg, Top Pros' Top Picks, StocksEarning, Jeff Bishop, Penny Invest, Stock Stars, Eagle Financial Publications, Stock Rich, Investors Underground, Trading Tips, BestOtc, The Stock Psycho, Top Gun, CNBC Breaking News, AllPennyStocks, StockHotTips, Energy and Capital, HotShotStocks, Wealth Daily, Chaikin PowerFeed, Cabot Wealth, BullRally, StockRich, FeedBlitz, DividendStocks, TipRanks, bullseyeoptiontrading, Summa Money, Earnings360, Louis Navellier, Today's Financial News, MadPennyStocks, Stockpalooza, Smartmoneytrading, MarketClub Options, PennyInvest, PennyStockVille, PennyTrader Publisher, Profit Confidential, BloomMoney, Wealth Whisperer, CRWEWallStreet, wealthmintrplus, Premium Stock Alerts, WiseAlerts, Round Up the Bulls, Stock Analyzer, Blaque Capital Stocks, wyatt research newsletter, Atomic Trades, AlphaShark Trading, Stock Fortune Teller, Stock Traders Chat, InvestorsUnderground, The Night Owl, StockMister, Standout Stocks, Penny Stock Finder, MicrocapVoice, Dawn Report, Momentum Traders, TradingPub, Penny Stock Rumble, Pennybuster, Early Investing, Trading with Larry Benedict, StockReport, Dynamic Wealth Report and Green Chip Stocks reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In recent months, crypto traders and investors are living in fear. As the value of digital currencies continues to rise, so does the number of attacks targeting people in the industry. What once started as online hacking has now turned into violent kidnappings, home invasions, and even torture.

One well-known case is that of Mohammed Arsalan from Karachi, Pakistan. Arsalan became famous for growing his small savings into a large fortune through cryptocurrency trading. He built a following of over 160,000 people online. But on Christmas Day in 2024, his success turned into a nightmare. Men pretending to be police kidnapped him, held him at gunpoint, and forced him to hand over his wallet passwords. Within minutes, his entire life savings were gone.

Arsalan’s case is not the only one. Reports show there have been over 230 physical attacks on crypto holders in the last year and a half. These attacks have happened across the world, from the U.S. to France, Spain, and Pakistan. Victims have been beaten, held hostage, and robbed. In some cases, even family members were harmed.

What makes these crimes easier is the very nature of blockchain technology. While transactions are public and open, they can also reveal how much money someone has. Criminals can use software to track wallets and find out where wealthy traders live. And since crypto transfers are fast and don’t need approval, it’s hard to stop a thief once they get access.

Because of this, many in the industry are now increasing their security. Some hire bodyguards, others avoid posting their locations online. Big companies like Kraken have even started using armed guards to protect their top staff. In France, where several violent attacks have happened, security firms say more crypto investors are asking for protection.

Even so, not many people are insured against such crimes. A report shows that only 10% of crypto holders have insurance for their digital assets. A few companies now offer special kidnap and ransom coverage, but it’s still new and costly.

For Arsalan, the pain of losing his savings was deep. He fell into depression and stayed offline for months. But he’s slowly getting back on his feet, trying to rebuild. He says that despite everything, he still believes in crypto.

These stories show that while crypto offers new chances for wealth, it also comes with serious risks. As the world of digital money grows, so must the safety and awareness of those who use it.

Major industry players like Coinbase Global Inc. (NASDAQ: COIN) may now need to come up with robust security policies to safeguard their staff and customers against this new evolving threat.

Coinbase Global Inc. (COIN), closed Thursday's trading session at $355.8, up 0.3808718%, on 6,704,285 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $142.58/$382.

Bit Mining Ltd. (BTCM)

QualityStocks, CryptoCurrencyWire, CurrencyNewsWire, StockEarnings, MarketClub Analysis, Schaeffer's, Wall St. Warrior, The Stock Dork, StocksEarning, smartmoneytrading, MarketBeat, INO Market Report, FreeRealTime and 247 Market News reported earlier on Bit Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent Bloomberg report, referencing a confidential source within the Bank of Korea, reports that the country’s top bank has put the next phase of its central bank digital currency (CBDC) testing on hold. The phase was originally expected to roll out in late 2025. The central bank has notified participating financial institutions that discussions surrounding the next phase will be put on hold for now.

The halt comes as South Korean regulators shift attention toward regulating privately issued stablecoins.

The Bank of Korea launched the first stage of its pilot, called “Project Han River,” in collaboration with seven major banks. The next phase was supposed to explore real-world uses, including merchant transactions and peer-to-peer transfers. However, some banks expressed concerns about the high implementation costs and the lack of a clear plan to introduce the currency into the market. These concerns have pushed the central bank to step back and reassess.

In the meantime, efforts are underway to establish a legal structure for stablecoins tied to the Korean won. The initiative is part of a broader digital finance bill—the Digital Asset Basic Act—which aims to set up a licensing system for stablecoin issuers. The bill includes guidelines for managing reserves and protecting users.

The policy shift also aligns with President Lee Jae-myung’s financial strategy. Since assuming office in June, Lee has pushed to make won-backed stablecoins a pillar of South Korea’s digital economy. His government supports a system that would allow firms with equity as low as $370,000 (₩500 million) to issue stablecoins, provided they meet regulatory standards.

Leaders of the Democratic Party see the move as critical for maintaining control over South Korea’s financial system. They argue that too much of the country’s crypto market depends on USD-backed stablecoins like USDC and USDT.

These foreign-issued tokens generated over $42 billion (₩57 trillion) in trading volume in just the first three months of 2025. Lawmakers warn that such a level of reliance could eventually weaken domestic monetary policy.

Korea’s Digital Asset Committee chair, Min Byeong-deok, has cautioned that without swift regulatory changes, the country risks falling behind in the global stablecoin landscape. He believes the stablecoin sector could rival other key industries like AI and semiconductors in strategic importance.

Reacting to the policy shift, eight major South Korean banks, including Shinhan, KB Kookmin, Nonghyup, and Woori, have come together to develop and launch a Korean won-based stablecoin.

Players in the crypto industry, such as Bit Mining Ltd. (NYSE: BTCM), will be watching how the blockchain landscape shapes up in South Korea as that could have ramifications upon the trajectory of the global crypto industry.

Bit Mining Ltd. (BTCM), closed Thursday's trading session at $2.3, up 2.6786%, on 60,070 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $1.22/$4.27.

Oragenics (OGEN)

QualityStocks, SmallCapRelations, InvestorBrandNetwork, MissionIR, BioMedWire, SeriousTraders, Stocks to Buy Now, StocksToBuyNow, Tip.Us, NetworkNewsWire, SmallCapSociety, RedChip, StockMarketWatch, BUYINS.NET, MarketBeat, StocksEarning, TopPennyStockMovers, FreeRealTime, MarketClub Analysis, Premium Stock Alerts, StockOodles, Streetwise Reports, The Stock Dork, The Online Investor, InvestorPlace, Wall Street Mover, Investopedia, StreetAuthority Daily and The Street reported earlier on Oragenics (OGEN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oragenics (NYSE American: OGEN) a clinical-stage biotechnology company developing intranasal therapeutics for neurological disorders, has closed its public offering of Series H Convertible Preferred Stock and Warrants, raising approximately $16.5 million in gross proceeds. The Company sold 660,000 units—each comprising one share of Series H Convertible Preferred Stock and one Warrant—at $25.00 per unit. The Warrants, exercisable immediately at the same price, could yield an additional $16.5 million if fully exercised. Net proceeds will fund clinical development of ONP-002 for concussion, repay a $3 million bridge note, and support R&D and general operations. Dawson James Securities acted as sole placement agent.

To view the full press release, visit https://ibn.fm/5Urvg

About Oragenics

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (“mTBI”), also known as concussion, and for treating Niemann Pick Disease Type C (“NPC”), as well as proprietary powder formulation and an intranasal delivery device. For more information, visit the company’s website at www.Oragenics.com

Oragenics (OGEN), closed Thursday's trading session at $1.53, up 6.25%, on 2,000,636 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $1.35/$75.6.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Meta is investing billions in hiring top-tier artificial intelligence experts, sparking discussions across the tech world about whether this bold strategy will ultimately pay off in the long run. According to reports, OpenAI's CEO, Sam Altman, has expressed frustration over Meta offering enormous bonuses—up to $100 million—to attract key personnel away from his firm. Despite OpenAI's already high compensation packages, several employees have left for Meta, raising internal alarms. OpenAI's Chief Research Officer, Mark Chen, reportedly described the departures as deeply personal, comparing them to a home invasion. In an internal message, he explained that the company was urgently reaching out to employees with offers from Meta, hoping to keep them from leaving. Still, Meta's leadership sees AI as the key to transforming its advertising model without relying on outside agencies. Analysts agree the company is making a long-term bet. While profits may not materialize quickly, laying the groundwork now could determine Meta's role in the future of AI. The scramble for top-tier talent shows how much work AI companies like D-Wave Quantum Inc. (NASDAQ: QBTS) have to do to get the right people to do the heavy lifting needed to bring to the market cutting-edge products and solutions in this rapidly evolving industry. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Thursday's trading session at $16.79, up 5.0688%, on 707,805 volume. The average volume for the last 3 months is 54,829,266 and the stock's 52-week low/high is $0.7505/$19.765.

Recent News

BluSky AI Inc. (OTC: BSAI)

The QualityStocks Daily Newsletter would like to spotlight BluSky AI Inc. (OTC: BSAI).

BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers

BSAI's vision is to empower the AI ecosystem, enabling companies to focus on innovation while they provide the critical infrastructure needed to succeed

By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience

BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable SkyMod solutions, stepped up its market visibility by upgrading to the OTCID tier, and partnered with industry accelerators, marking significant progress toward becoming an essential AI player in the data center space.

BluSky AI Inc. (OTC: BSAI) is pioneering the next generation of AI infrastructure through modular, rapidly deployable data centers that meet the escalating compute demands of artificial intelligence, machine learning, and high-performance computing. The company’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions.

Rather than betting on individual AI applications, BluSky AI addresses the universal need for compute power—positioning itself as a foundational layer in the AI revolution. Its infrastructure-first approach enables clients to focus on innovation while the company delivers the critical backbone powering tomorrow’s breakthroughs.

BluSky AI is headquartered in Salt Lake City, Utah.

Products

BluSky AI’s core offering is its SkyMod series of modular data centers—pre-assembled, scalable compute units designed specifically for AI workloads. The flagship SkyMod One delivers 1 MW of compute power in a compact 1,400-square-foot footprint, while the SkyMod XL offers 1.7 MW in 3,000 square feet. These units are fully assembled off-site, tested, and shipped ready for plug-and-play deployment either on BluSky-owned land or client facilities.

SkyMod modules integrate NVIDIA GPUs and are optimized for high-density AI applications such as generative AI, large language models, inference engines, and scientific computing. Built for rapid scaling and high efficiency, each system includes advanced cooling, secure infrastructure, and dynamic workload balancing to support evolving client needs.

The company’s data centers are engineered for sustainability, incorporating renewable energy sources like solar, wind, and geothermal where available. By deploying on powered land assets, BluSky AI shortens lead times and lowers costs, creating a fast, flexible alternative to traditional monolithic data centers.

Market Opportunity

The global data center market was valued at $347.6 billion in 2024 and is projected to reach $652.0 billion by 2030, growing at a CAGR of 11.2%, driven by the rapid expansion of AI, machine learning, and IoT adoption, according to Grand View Research. As enterprises demand faster, more scalable compute solutions, modular infrastructure like BluSky AI’s SkyMod series offers a compelling alternative to legacy data center models.

With North America accounting for over 40% of the global market and the U.S. expected to grow at a 10.7% CAGR from 2025 to 2030, BluSky AI is well-positioned to capture demand for AI-optimized infrastructure that can be deployed rapidly and cost-effectively. By focusing on GPU-centric, modular deployments tied to energy infrastructure, the company addresses a growing gap between compute demand and deployment speed in the AI era.

Leadership Team

Trent D’Ambrosio, Chief Executive Officer, is a seasoned executive with a track record in telecommunications, hedge fund management, and natural resource development. He previously sold the first transatlantic fiber cable, built a successful gold mining company, and now leads BluSky AI with a vision to revolutionize AI infrastructure through strategic energy integration and rapid deployment.

Julien Bedard, Chief Technology Officer, is a pioneering technologist known for launching the first Bitcoin escrow and anti-fraud service. At BluSky AI, he oversees cloud architecture, cybersecurity, infrastructure automation, and the development of AI-native data center technology, ensuring scalability and resilience across deployments.

Dan Gay, Chief Operating Officer, has Fortune 500 executive leadership in telecom, technology, and energy, as well as start-up experience with finance and blockchain companies. At MCI and Qwest, he launched new service and sales centers, and directed National Account Sales. He has been a successful CMO in brand creation, product development, partnerships, and revenue generation programs to expand company awareness, sales, and revenue.

Investment Considerations
  • BluSky AI delivers mission-critical infrastructure supporting AI, ML, and HPC applications.
  • SkyMod modules are prefabricated, scalable, and optimized for rapid plug-and-play deployment.
  • The company’s data center designs emphasize sustainability with support for renewable energy.
  • BluSky’s infrastructure-first model addresses universal AI compute needs across industries.
  • A veteran leadership team combines expertise in telecom, finance, and advanced technologies.

BluSky AI Inc. (OTC: BSAI), closed Thursday's trading session at $3.3, up 30.2803%, on 1,922 volume. The average volume for the last 3 months is 3,370 and the stock's 52-week low/high is $0.118/$5.49.

Recent News

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

ESGold is celebrating the successful close of a private placement funding effort that will generate important financing for the company's planned launch of a mine tailings cleanup and reclamation project later this year

The financing drive was oversubscribed by more than 11%, which ESGold executives hail as evidence that investors like the company's strategy for generating revenue

The company holds 265 mining claims on the historic Montauban mine site in Quebec, covering 13,116 hectares (about 32,410 acres) of gold and silver exploration

ESGold expects to begin mill circuit production on the tailings cleanup later this year

Mica recovered in the reclamation would be used in an innovative concentrate that is stronger than concrete and usable for construction materials such as bricks, parking columns, and highway Jersey barriers

ESGold (CSE: ESAU) (OTCQB: ESAUF) , a pre-production gold and silver resource developer operating in Canada, has closed its recent non-brokered private placement funding effort after seeing a successful raise of $3,649,171 in aggregate gross proceeds to assist its pending processing of a site's abandoned tailings.

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Thursday's trading session at $1.0065, up 5.9474%, on 193,610 volume. The average volume for the last 3 months is 228,840 and the stock's 52-week low/high is $0.0221/$1.07.

Recent News

Calidi Biotherapeutics Inc. (NYSE American: CLDI)

The QualityStocks Daily Newsletter would like to spotlight Calidi Biotherapeutics Inc. (NYSE American: CLDI).

While studying why non-human primates aren't as likely to suffer from certain cancers when compared to humans, UC Davis scientists discovered a genetic mutation that could explain this anomaly. Their findings were published in the Nature Communications journal. This discovery could open the door to the development of more powerful treatments for cancer. The researchers focused on Fas Ligand, an immune protein that helps in attacking tumor cells. This protein is present in both human and non-human primates like chimpanzees. The scientists discovered that in humans, a small mutation makes FasL to be easily deactivated by a tumor-linked enzyme called plasmin. This vulnerability is unique to humans because other primates don't manifest the same weakness. This research opens the possibility of developing treatments targeting plasmin in order to keep the immune cells intact and able to combat tumors. Combining immunotherapies with special antibodies trained to protect FasL or using plasmin inhibitors could therefore render immunotherapy treatments more effective than they currently are against solid tumors. As more entities, such as Calidi Biotherapeutics Inc. (NYSE American: CLDI), advance their programs aimed at improving immunotherapy success rates, a time could come when solid tumors previously regarded as hard to treat respond well to new treatments and patients get the desired clinical outcomes. 

Calidi Biotherapeutics Inc. (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering proprietary technology that empowers the immune system to combat cancer. Calidi’s innovative, off-the-shelf cell-based platforms use allogeneic stem cells to deliver potent oncolytic viruses (OVs) across multiple oncology indications, including high-grade glioma (brain cancers) and solid tumors. In addition, Calidi has presented a breakthrough systemic technology, RTNova, which utilizes an exteracellular enveloped virotherapy. RTNova is pre-clinical and has been extremely well-received by market analysts and large-cap biopharma – opening the door for potential collaboration.

These cell-based platforms are engineered to protect, amplify, and enhance the efficacy of oncolytic viruses, resulting in improved patient safety and potentially advancing treatment outcomes for metastatic disease. By employing a dual approach that combines OV delivery with immune activation, Calidi’s therapies aim to not only treat but potentially prevent the spread of metastatic cancers.

The company’s development pipeline leverages this technology to address pressing needs in cancers such as glioblastoma (brain cancer), metastatic melanoma, triple-negative breast cancer, head & neck cancer, and lung cancer. Calidi’s approach has shown early signals of efficacy and safety, establishing it as a distinctive player in the growing OV market, which is projected to increase significantly in value over the next decade.

Calidi is headquartered in San Diego, California.

Products

Calidi’s product pipeline includes advanced cell-based platforms targeting a variety of oncology indications, each designed to harness the power of oncolytic virotherapy for improved cancer treatment outcomes.

  • NeuroNova (CLD-101): A platform designed for treating high-grade gliomas (HGG), NeuroNova employs neuronal stem cells combined with an engineered adenovirus (CRAD-s-Pk7) to selectively target glioma cells. After a successful Phase 1 safety study in newly diagnosed HGG, NeuroNova has now progressed into Phase 1/1b trials for recurrent cases. FDA clearance for a Phase 1b/2 trial at Northwestern University was received in September 2024, with patient enrollment expected to begin in Q1 2025. This trial will utilize multiple-dose intracerebral administration to maximize safety and efficacy in newly diagnosed HGG patients.
  • SuperNova (CLD-201): Built on Calidi’s foundational technology, SuperNova utilizes an engineered Vaccinia virus (CAL1) delivered via allogeneic adipose-derived mesenchymal stem cells to target advanced solid tumors, including head & neck, triple-negative breast cancer, and soft tissue sarcomas. Early studies with autologous stem cells demonstrated both safety and promising efficacy, and Calidi plans to begin a Phase 1 trial with multiple dose regimens for SuperNova in the coming months.
  • RTNova (CLD-400): Calidi’s systemic delivery platform for lung and metastatic cancers, RTNova employs an extracellular enveloped virotherapy (envRT-01) technology for intravenous (IV) administration, simplifying the treatment process and expanding its potential applications. Currently in preclinical stages, RTNova focuses on demonstrating efficacy and safety through systemic administration. A clinical trial targeting metastatic lung cancer is anticipated for Q2 2026, using a single-arm monotherapy with dose escalation. Calidi has partnered with SIGA Technologies (NASDAQ: SIGA) to support the development of this program.

Market Opportunity

The global oncology drugs market was valued at $201.75 billion in 2023 and is projected to grow to $518.25 billion by 2032, with a CAGR of 11.3%. The oncolytic virotherapy market in particular is growing rapidly, driven by increasing approval rates and significant unmet needs.

The market for OV treatments is expected to expand from one approved product generating $150 million in the U.S. in 2021 to 6-8 approved therapies generating $2.4 billion by 2030. As a leader in OV technology, Calidi is well-positioned to address these high-demand areas in oncology.

Alongside global trends, the American Cancer Society projects nearly two million new cancer diagnoses in the U.S. in 2024, reflecting a 28% increase since 2010. This underscores the urgent need for novel therapies that not only treat disease progression but also enhance patient quality of life, reinforcing the demand for Calidi’s innovative approaches.

Management Team

Allan Camaisa, CEO, Chairman, and co-founder, is a seasoned leader with extensive experience in scaling businesses to successful exits. Mr. Camaisa previously led High Technology Solutions, growing it from two employees to over 500 with $50 million in revenue. He also served as CEO of Parallel6 Inc. and is a U.S. Naval Academy graduate with further studies at Harvard Business School.

Antonio Santidrian, Ph.D., Chief Scientific Officer, leads all research and development initiatives at Calidi and is the coinventor of the company’s CLD-201 (Supernova) and CLD-400 (RTNova) platforms. Since joining Calidi in 2015, he has applied his 20+ years of expertise in academia and biotech, focusing on anti-cancer translational research, to drive the company’s innovative drug pipeline. Before Calidi, Dr. Santidrian led translational studies at The Scripps Research Institute, advancing treatments for breast cancer metastasis, and contributed to the development of ACADRA for chronic lymphocytic leukemia (CLL) at the University of Barcelona, Spain.

Boris Minev, M.D., President of Medical and Scientific Affairs, is a renowned physician-scientist with expertise in Immuno-Oncology, stem cell biology, and oncolytic viruses. Previously, Dr. Minev served as Director of Immunotherapy and Translational Oncology at Genelux Corporation and remains an adjunct professor at the Moores UCSD Cancer Center. His background includes research at the National Cancer Institute.

Andrew Jackson, CFO, has held executive finance roles with experience in biotech and clinical-stage companies, including Eterna Therapeutics and Ra Medical Systems. Mr. Jackson holds an MSBA in Finance from San Diego State University and a BSB in Accounting from the University of Minnesota.

Calidi Biotherapeutics Inc. (NYSE American: CLDI), closed Thursday's trading session at $0.2458, up 5.0876%, on 19,917 volume. The average volume for the last 3 months is 1,544,170 and the stock's 52-week low/high is $0.2027/$3.89.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF) is embracing the shift head-on as automation reshapes hospitality, and hotel operators are under pressure to find cost-effective, scalable solutions that combat labor shortages, streamline operations, and elevate guest experiences. The company holds an ambitious plan to lead the industry through artificial intelligence ("AI")-powered hotel automation and strategic acquisitions. Recent moves in key California markets were featured in an article that reads, "Nightfood announced a $36.93 million LOI to acquire the Hilton Garden Inn in Rancho Mirage, California, a 120-room hotel adjacent to Disney's forthcoming Cotino residential resort community… Situated in a high-traffic tourist corridor, the Rancho Mirage hotel is set to become a site for showcasing Nightfood's RaaS technology – including its currently deployed Skytech Laundry helper – and will serve as a future model for retrofitting other full-service hotels… This move follows Nightfood's April announcement of a $41 million acquisition of a Holiday Inn in Victorville, California… the Victorville location will become Nightfood's first RaaS model hotel, demonstrating how automation can improve profitability, reduce staffing burdens, and optimize service delivery."

To view the full article, visit https://ibn.fm/Y2zWP

Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.

With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.

Operations

Nightfood Holdings is focused on two core business areas:

  • Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
  • Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.

Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.

Market Opportunity

The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.

  • Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
  • Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
  • Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.

Industry Impact: The Future of Smart Hotels

NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.

Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:

  • Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
  • Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
  • Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.

Future Vision & Growth Strategy

Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.

Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.

Team Expertise as a Strategic Advantage

In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.

This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.

Investment Considerations
  • Dual Growth Strategy – NGTF combines hotel acquisitions with AI-powered automation, creating an integrated model that maximizes operational efficiency and revenue potential.
  • Expanding Robotics-as-a-Service (RaaS) – Subscription-based robotic automation solutions designed to reduce operational costs and address labor shortages for hotel operators.
  • Strategic Hotel Acquisitions – Acquiring a variety of hospitality assets, from midscale to luxury, to serve as testing grounds for AI-driven automation and to drive profitability.
  • Proven Market Demand – Rising labor costs and increasing adoption of service robotics are fueling demand for automation in hospitality, positioning NGTF as an early leader in the sector.
  • Scalable & Revenue-Generating Model – By owning hotels and offering RaaS to third-party operators, NGTF is building a diversified, high-growth business model.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Thursday's trading session at $0.0182, up 5.814%, on 125,182 volume. The average volume for the last 3 months is 221,220 and the stock's 52-week low/high is $0.0053/$0.0571.

Recent News

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).

Nutriband and Kindeva have completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a major milestone in the path to FDA approval

Updated analyst report raises NTRB's price target to $15.00 and reiterates an Outperform rating, citing favorable trial pathway and strong execution

Aversa abuse-deterrent tech is protected by international patents and may address a global unmet need in safe pain management

NTRB boosting their profile and credibility with its recent membership to the Russel Indexes

The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to a growing demand for smarter, safer delivery systems. As policymakers, healthcare providers, and regulators seek solutions that balance medical necessity with public safety, innovative technologies are emerging that could reshape how these powerful drugs are administered. One company aiming to bridge this gap is Nutriband (NASDAQ: NTRB). Recently, Nutriband announced it has completed commercial manufacturing process scale-up for its lead product, AVERSA(TM) Fentanyl, in partnership with global contract manufacturer Kindeva Drug Delivery. The achievement represents a critical step toward launching the world's first abuse-deterrent transdermal fentanyl patch.

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Investment Considerations
  • Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
  • AVERSA technology can be incorporated into any transdermal patch.
  • The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
  • Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
  • In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.

Nutriband Inc. (NASDAQ: NTRB), closed Thursday's trading session at $9.91, off by 7.556%, on 449 volume. The average volume for the last 3 months is 145,893 and the stock's 52-week low/high is $3.7223/$11.78.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) was featured in a recent article discussing substantial deficit in the platinum market and a sharp rally in prices due to the tightening supply-demand balance. The piece reads, "Platinum Group Metals is working to address a portion of the world's platinum need. The company's Waterberg project, on the Northern Limb of South Africa's Bushveld Complex — the planet's prime platinum reserve — is being advanced toward development and construction. The September 2024 Waterberg DFS update shows Waterberg is being designed as a fully mechanized, underground mine targeting platinum as well as other key metals, including palladium, rhodium and gold, (‘4E' or ‘PGM') with copper and nickel byproducts."

To view the full article, visit https://ibn.fm/ZJKcB

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Thursday's trading session at $1.55, off by 3.125%, on 12,952 volume. The average volume for the last 3 months is 1,510,389 and the stock's 52-week low/high is $0.99/$2.27.

Recent News

SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

The company announced its expansion into the $395 billion global data center market as a developer, owner, and strategic partner.

The move underscores SolarBank's commitment to integrating renewable energy in diverse, emerging sectors.

AI data centers are projected to need 30 times more power by 2035, creating a critical opportunity for clean energy solutions.

The company joins tech giants and specialized data center providers focused on sustainability and resilience in digital infrastructure.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) , a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., continues its focus on  the rapidly growing data center sector, highlighting its plan to serve as a developer, owner, and partner in one of the world's fastest-expanding infrastructure markets. This focus comes as the global data center industry is forecast to reach $395 billion by 2030, fueled by explosive demand for cloud computing, big data, and artificial intelligence technologies ( https://ibn.fm/8SI6a ).

SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

SolarBank has offices in Toronto, Ontario and New York.

Projects

SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

SolarBank Corp. (NASDAQ: SUUN), closed Thursday's trading session at $1.48, off by 1.9868%, on 38 volume. The average volume for the last 3 months is 559,506 and the stock's 52-week low/high is $1.23/$6.43.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) , a critical metals technology company developing scalable rare earth element ("REE") refining infrastructure in North America, marked a significant milestone in the development of a domestic REE supply chain. Ucore was featured in a recent article that discussed the groundbreaking of its Louisiana Strategic Metals Complex ("SMC") in Alexandria. "This facility represents the company's first commercial REE refining operation and is poised to play a pivotal role in reducing North America's reliance on foreign sources for critical minerals… The Louisiana SMC is designed to utilize Ucore's proprietary RapidSX(TM) technology, an advanced solvent extraction process that offers a more efficient and environmentally friendly method for separating REEs… The U.S. Department of Defense (‘DoD') has recognized the strategic importance of the Louisiana SMC by providing $18.4 million in funding to accelerate the installation of the RapidSX technology at the facility. This investment underscores the DoD's commitment to strengthening the domestic supply chain for critical minerals essential to national security and technological advancement."

To view the full article, visit https://ibn.fm/5Otn5

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

 

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Thursday's trading session at $0.84, off by 0.591716%, on 46,416 volume. The average volume for the last 3 months is 202,070 and the stock's 52-week low/high is $0.33/$1.64.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Thursday's trading session at $0.3533, up 0.9428571%, on 54,124 volume. The average volume for the last 3 months is 265,930 and the stock's 52-week low/high is $0.0139/$1.65.

Recent News

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Thursday's trading session at $3.38, up 1.8072%, on 201 volume. The average volume for the last 3 months is 276,760 and the stock's 52-week low/high is $1.1/$6.01.

Recent News

Solowin Holdings (NASDAQ: SWIN)

The QualityStocks Daily Newsletter would like to spotlight Solowin Holdings (NASDAQ: SWIN).

Solowin Holdings (NASDAQ: SWIN) is a versatile financial services provider focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin is licensed by the Hong Kong Securities and Futures Commission and offers access to a full suite of financial services through its secure, one-stop electronic platform, Solomon Win.

Driven by a vision to create a modernized financial services infrastructure, especially to bridging traditional finance and the Web3 technology, Solowin has prioritized innovation, agility, and client-first experiences. The firm has experienced robust growth, aligning itself with evolving capital markets and emerging technologies. Its investment strategy is designed to enable seamless access to capital markets and diversified investment opportunities through cutting-edge financial technology.

Solowin is committed to building a global brand rooted in client success, regulatory compliance, and operational excellence. Its mission is to empower clients with flexible, integrated tools to grow and protect wealth in an increasingly complex financial landscape.

Portfolio

Solowin’s operations span five core verticals: securities brokerage, investment banking, asset management, virtual assets, and wealth management. Through its Solomon Win platform, the company provides individual and institutional clients with seamless access to financial markets around the world.

In investment banking, Solowin offers strategic advisory and capital formation services including IPO/SPAC listings, follow-on offerings, private placements, and debt financing. Its team assists issuers in aligning their business objectives with optimized listing strategies and investor targeting. Solowin also supports clients through financial advisory services such as mergers and acquisitions, business restructuring, and capital strategy development, alongside risk management and tax compliance services.

In wealth and asset management, Solowin delivers personalized financial planning via its securities brokerage and integrated investment solutions. Clients can access both in-house funds and top-tier international funds through the Solomon VA+ App, which also supports managed account services. On the frontier of fintech, Solowin offers Web3-based solutions such as virtual asset ETFs, cryptocurrencies, security token offerings, and tokenized real-world assets—positioning itself as a key player in the evolving digital finance space.

Market Opportunity

Solowin operates at the intersection of traditional finance and Web3 innovation, targeting a rapidly expanding global wealth management and fintech market. According to a report by Boston Consulting Group, global assets under management are projected to reach $147.4 trillion by 2027, up from $111.2 trillion in 2021, driven by increased demand for personalized and tech-enabled financial services. Additionally, the virtual asset market is poised for significant growth, with Boston Consulting Group forecasting that the tokenization of global illiquid assets could reach $16 trillion by 2030.

Hong Kong’s progressive stance on virtual assets has also positioned it as a regional hub for digital finance. Regulatory support from the Securities and Futures Commission has opened the door for regulated crypto trading platforms and tokenized asset solutions, which aligns with Solowin’s digital-first approach.

As wealth migrates toward hybrid portfolios combining traditional and virtual assets, Solowin is uniquely positioned to capitalize on both sectors.

Leadership Team

Peter Lok, Chief Executive Officer, an accomplished finance professional with extensive expertise in fund management, capital markets, and fundraising. His strategic insights in finance and capital allocation have been instrumental in driving capital growth.

Lily Liu, Chief Financial Officer, has more than a decade of experience in corporate finance, investment banking, and financial services. Her background includes IPOs, mergers and acquisitions, and private placements in both Hong Kong and U.S. capital markets, with a strong focus on risk management.

Ben Cheng, Chief Operating Officer, has 15+ years of operational expertise in securities brokerage and asset management. His specialties include regulatory compliance and Anti-Money Laundering/Counter-Financing of Terrorism (AML/CFT) oversight.

Investment Considerations
  • Solowin Holdings offers diversified exposure to both traditional financial services and next-generation digital assets.
  • The company leverages regulatory licenses in Hong Kong to serve global high-net-worth and institutional investors.
  • Solowin delivers brokerage, investment banking, asset management, and Web3 services across its Solomon Win and Solomon VA+ platforms, offering clients seamless access to both traditional and digital financial solutions.
  • Strategic investments, such as its $10M contribution to AlloyX, an Asia-based stablecoin infrastructure firm, highlight Solowin’s proactive role in fintech innovation.
  • Led by seasoned executives with decades of capital markets experience, the company is positioned for sustained global expansion.

Solowin Holdings (NASDAQ: SWIN), closed Thursday's trading session at $3.84, up 7.563%, on 3,691 volume. The average volume for the last 3 months is 279,804 and the stock's 52-week low/high is $1.16/$3.9197.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.